UCSF Dermatology Grand Rounds - 24 April 2024

Wednesday, April 24 at 8:10 am - 10:15 am Add to Calendar 2024-04-24 15:10:00 2024-04-24 17:15:00 UCSF Dermatology Grand Rounds - 24 April 2024 GRAND ROUNDS AND PATIENT VIEWINGPox! Kieron Leslie, MD, Professor of Clinical Dermatology, UCSF Objectives: 1. To understand the historical context of how skin disease can marginalize sexual and gender minorities 2.Clinical features of new variant Mpox infection 3.To review treatment and vaccination strategies for Mpox Speaker Disclosures: Kieron Leslie, MD has disclosed that he has no financial relationships to disclose.  Moderator Disclosures: Anna Haemel, MD has disclosed that she is an advisor or reviewer for CSL Behring, a consultant for Guidepoint LLC and receives a research grant from Priovant. Planner Disclosures: Ilona Frieden, MD has disclosed that she is a consultant for Venthera Bridgebio, Data Safety Monitoring Advisory Board for Pfizer, and Data Reviewer on the NCT02913612 Pediatric Trials Network-NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01). Kelly Cordoro, MD, Hunter Shain, PhD and Amanda Twigg, MD have stated they have no relationships to disclose. 1600 Divisadero Street Herbst Hall Auditorium San Francisco, CA 94115 United States View on Map Department Of Dermatology Laura.Harrison@ucsf.edu America/Los_Angeles public

1600 Divisadero Street
Herbst Hall Auditorium
San Francisco, CA 94115
United States

View on Map

GRAND ROUNDS AND PATIENT VIEWING
Pox!

Kieron Leslie, MD, Professor of Clinical Dermatology, UCSF

Objectives:

1. To understand the historical context of how skin disease can marginalize sexual and gender minorities

2.Clinical features of new variant Mpox infection

3.To review treatment and vaccination strategies for Mpox

Speaker Disclosures: Kieron Leslie, MD has disclosed that he has no financial relationships to disclose. 

Moderator Disclosures: Anna Haemel, MD has disclosed that she is an advisor or reviewer for CSL Behring, a consultant for Guidepoint LLC and receives a research grant from Priovant.

Planner Disclosures:
Ilona Frieden, MD has disclosed that she is a consultant for Venthera Bridgebio, Data Safety Monitoring Advisory Board for Pfizer, and Data Reviewer on the NCT02913612 Pediatric Trials
Network-NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01).
Kelly Cordoro, MD, Hunter Shain, PhD and Amanda Twigg, MD have stated they have no relationships to disclose.